NeuBase Therapeutics, Inc. Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NeuBase Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NeuBase Therapeutics, Inc. for January 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 2016 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Option Exercise | A | 3.62 | 80,000 | 289,600 | 80,000 | |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.52 | 200 | 704 | 865,754 | 865.6 K to 865.8 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.52 | 100 | 352 | 865,554 | 865.5 K to 865.6 K (+0.01 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.53 | 1,000 | 3,530 | 865,454 | 864.5 K to 865.5 K (+0.12 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.54 | 1,200 | 4,248 | 864,454 | 863.3 K to 864.5 K (+0.14 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.55 | 850 | 3,018 | 863,254 | 862.4 K to 863.3 K (+0.10 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.56 | 100 | 356 | 862,404 | 862.3 K to 862.4 K (+0.01 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.57 | 100 | 357 | 862,304 | 862.2 K to 862.3 K (+0.01 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.59 | 400 | 1,436 | 862,204 | 861.8 K to 862.2 K (+0.05 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.60 | 200 | 720 | 861,804 | 861.6 K to 861.8 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.65 | 200 | 730 | 861,604 | 861.4 K to 861.6 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.66 | 200 | 732 | 861,404 | 861.2 K to 861.4 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.67 | 200 | 734 | 861,204 | 861 K to 861.2 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.70 | 100 | 370 | 861,004 | 860.9 K to 861 K (+0.01 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.73 | 200 | 746 | 860,904 | 860.7 K to 860.9 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.75 | 400 | 1,500 | 860,704 | 860.3 K to 860.7 K (+0.05 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.81 | 500 | 1,905 | 860,304 | 859.8 K to 860.3 K (+0.06 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.88 | 200 | 776 | 859,804 | 859.6 K to 859.8 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.92 | 100 | 392 | 859,604 | 859.5 K to 859.6 K (+0.01 %) |
| Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | HIRSCHMAN ORIN | Director | Option Exercise | A | 5.14 | 60,000 | 308,400 | 60,000 | |
| Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | Almenoff June Sherie | Director | Option Exercise | A | 5.14 | 60,000 | 308,400 | 60,000 | |
| Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | Riedhammer Thomas M | Director | Option Exercise | A | 5.14 | 60,000 | 308,400 | 60,000 | |
| Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | GREENSTEIN IRA A | Director | Option Exercise | A | 5.14 | 60,000 | 308,400 | 60,000 | |
| Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | Backenroth Samuel | Chief Financial Off ... | Grant | A | 0.00 | 130,000 | 0 | 136,199 | 6.2 K to 136.2 K (+2,097.11 %) |
| Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Grant | A | 0.00 | 350,358 | 0 | 859,504 | 509.1 K to 859.5 K (+68.81 %) |